NCT03784014 2026-04-29MULTISARCInstitut National de la Santé Et de la Recherche Médicale, FrancePhase 3 Completed603 enrolled
NCT02386826 2023-09-21INC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeSCRI Development Innovations, LLCPhase 1 Completed65 enrolled